Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 25.4 CHF 3.67% Market Closed
Market Cap: 146.6m CHF

Intrinsic Value

The intrinsic value of one XLS stock under the Base Case scenario is 1.03 CHF. Compared to the current market price of 25.4 CHF, Xlife Sciences AG is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XLS Intrinsic Value
1.03 CHF
Overvaluation 96%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Xlife Sciences AG

What is Valuation History?
Ask AI Assistant
What other research platforms think about XLS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is XLS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Xlife Sciences AG.

Explain Valuation
Compare XLS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about XLS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xlife Sciences AG

Current Assets 13.1m
Cash & Short-Term Investments 51.6k
Receivables 12.9m
Other Current Assets 127.8k
Non-Current Assets 523.1m
Long-Term Investments 260.5m
PP&E 210.8k
Intangibles 261.3m
Other Non-Current Assets 1.2m
Current Liabilities 12.2m
Accounts Payable 920.6k
Other Current Liabilities 11.2m
Non-Current Liabilities 220.7m
Long-Term Debt 53.9m
Other Non-Current Liabilities 166.7m
Efficiency

Free Cash Flow Analysis
Xlife Sciences AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Xlife Sciences AG

Revenue
839.4k CHF
Cost of Revenue
-317.5k CHF
Gross Profit
521.9k CHF
Operating Expenses
-20m CHF
Operating Income
-19.5m CHF
Other Expenses
50.2m CHF
Net Income
30.8m CHF
Fundamental Scores

XLS Profitability Score
Profitability Due Diligence

Xlife Sciences AG's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional Net Margin
Strong 3Y Average Net Margin
Exceptional Gross Margin
Sustainable 3Y Average Gross Margin
42/100
Profitability
Score

Xlife Sciences AG's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

XLS Solvency Score
Solvency Due Diligence

Xlife Sciences AG's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
34/100
Solvency
Score

Xlife Sciences AG's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XLS Price Targets Summary
Xlife Sciences AG

There are no price targets for XLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Xlife Sciences AG
does not pay dividends
Shareholder Yield

Current shareholder yield for XLS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one XLS stock?

The intrinsic value of one XLS stock under the Base Case scenario is 1.03 CHF.

Is XLS stock undervalued or overvalued?

Compared to the current market price of 25.4 CHF, Xlife Sciences AG is Overvalued by 96%.

Back to Top